| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-11 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-09 |